Listed Pharmaceutical Companies, ‘Highly Dependent on the Domestic Market’

Published: 2014-09-15 09:31:00

Updated: 2014-09-15 09:31:00

It was investigated that domestic listed pharmaceutical companies earn 90% of their revenue from the local market.

Based on the report of the first half of 2014 submitted to the Financial Supervisory Service, the export share out of the total sales of KOSPI, and KOSDAQ-listed pharmaceutical companies was only 10 percent. It can be analyzed that 90% of the total sales in the domestic market is ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.